Prevalence of childhood cancer survivors increasing
the ONA take:
According to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers have found that the prevalence of childhood cancer survivors is increasing, and most of those who have survived at least 5 years beyond diagnosis may have at least one comorbidity.
Using nine U.S. Surveillance, Epidemiology, and End Results (SEER) registries and data from the Childhood Cancer Survivor Study (CCSS), researchers estimated that there are 388,501 childhood cancer survivors in the United States, an increase of nearly 60,000 from the previous 2005 National Cancer Institute estimate.
Researchers found that approximately 84% of survivors have survived 5 or more years since diagnosis. The study also showed that about 70% of childhood cancer survivors have a mild or moderate chronic condition and about 32% have a severe, disabling, or life-threatening chronic condition.
The findings suggest that more needs to be done to effectively decrease morbidity burden in childhood cancer survivors, particularly those with neurocognitive dysfunction, self-reported functional impairment, activity limitations, impaired mental health, pain, or anxiety and fear.
Prevalence of childhood cancer survivors is increasing, and those who survived at least 5 years beyond diagnosis have at least one comorbidity.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|